Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.71
Delayed Data
As of 3:59pm ET
 +0.085 / +5.25%
Today’s Change
0.97
Today|||52-Week Range
2.12
-9.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-50.0M5.6M-29.2M-42.7M
 
 
 
 
 
Depreciation223.5K176.5K200.2K404.2K
 
 
 
 
 
Total Other Cash Flow44.5M-21.5M4.0M5.4M
 
 
 
 
 
Funds From Operations-5.3M-15.8M-24.9M-36.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-100.1K254.6K-1.0M-1.3M
 
 
 
 
 
Net Cash Flow - Operating Activities-5.2M-16.0M-23.9M-35.6M
 
 
 
 
 
 
InvestingCapital Expenditures-366.6K-183.8K-663.3K-1.2M
 
 
 
 
 
Fixed Asset Disposal--30.2M0.000.00
 
 
Net Assets From Acquisitions 0.00-2.8M0.000.00
 
 
Net Cash Flow Investing-398.7K27.2M-671.8K-1.3M
 
 
 
 
 
 
FinancingShort Term Borrowings--0.000.000.00--
Long Term Borrowings--7.0M3.8M27.8M
 
 
 
 
Long Term Debt Reduction-20.3K-71.0K-1.3M-6.0M
 
 
 
 
 
Net Proceeds Stock Sale6.5M7.2M2.7M39.6M
 
 
 
 
 
Common Preferred Redeemed0.000.00-100.9K0.00
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total-111.4K-100.0K-100.0K0.00
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.003.0M14.6K659.0K
 
 
 
 
Net Cash Flow - Financing6.3M11.1M5.1M60.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
 
Net Change In Cash780.7K22.2M-19.5M23.8M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account